![](http://www.thielerlaw.com/assets/news//NPN44oxZ_Avinger logo.jpg)
Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Avinger Inc (NASDAQ: AVGR) violated securities laws in connection with certain financial statements.
The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Avinger Inc (NASDAQ: AVGR) concerning whether a series of statements by Avinger Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On July 12, 2016, Avinger revealed that it expects total revenue for the second quarter of 2016 to be lower than the consensus estimate amount. Avinger now expects 2016 revenue to be in the range of $19 - $23 million, compared to previous guidance for revenue in the range of $25 - $30 million.
Based in Redwood City, CA, and founded in 2007 Avinger Inc designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease.
If you purchased shares of Avinger Inc (NASDAQ: AVGR) on or before July 12, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.
Thieler Law Corp
2534 State Street - Suite 406,
San Diego, CA 92101
by
email: mail@thielerlaw.com
or
telephone at +1 (619) 377 - 4324
or
visit our website http://www.thielerlaw.com/
or
Facsimile: +1 (619) 785 – 3185